BHYSX
Price
$7.08
Change
-$0.00 (-0.00%)
Updated
Jul 31 closing price
Net Assets
27.34B
NCOIX
Price
$17.65
Change
-$0.01 (-0.06%)
Updated
Jul 31 closing price
Net Assets
568.12M
Interact to see
Advertisement

BHYSX vs NCOIX

BHYSX vs NCOIX Comparison Chart in %
View a ticker or compare two or three
VS
BHYSX vs. NCOIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHYSX is a Hold and NCOIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BHYSX has more cash in the bank: 27.3B vs. NCOIX (568M). NCOIX pays higher dividends than BHYSX: NCOIX (7.43) vs BHYSX (6.42). BHYSX was incepted earlier than NCOIX: BHYSX (28 years) vs NCOIX (16 years). BHYSX (0.93) is less costly to investors than NCOIX (0.84). NCOIX is a more actively managed with annual turnover of: 170.00 vs. BHYSX (64.00). BHYSX has a lower initial minimum investment than NCOIX: BHYSX (5000) vs NCOIX (100000). NCOIX annual gain was more profitable for investors over the last year : 6.62 vs. BHYSX (4.80). NCOIX return over 5 years is better than : 25.43 vs. BHYSX (21.67).
BHYSXNCOIXBHYSX / NCOIX
Total Expense Ratio0.910.77118%
Annual Report Gross Expense Ratio0.930.84111%
Fund Existence28 years16 years-
Gain YTD1.5952.64860%
Front LoadN/AN/A-
Min. Initial Investment50001000005%
Min. Initial Investment IRAN/AN/A-
Net Assets27.3B568M4,806%
Annual Yield % from dividends6.427.4386%
Returns for 1 year4.806.6272%
Returns for 3 years26.5229.5190%
Returns for 5 years21.6725.4385%
Returns for 10 years67.9872.0494%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSGFX25.680.18
+0.71%
Morgan Stanley Inst Global Franchise C
BRUHX19.050.07
+0.37%
MFS Blended Research Value Equity I
SUFCX42.530.03
+0.07%
NAA Mid Growth C
FSLZX54.870.04
+0.07%
Fidelity Advisor Stock Selec Mid Cp Z
TAMVX38.28-0.13
-0.34%
T. Rowe Price Mid-Cap Value Adv